T

Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488

Watchlist Manager
Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
Watchlist
Price: 4.14 CNY 1.22%
Market Cap: 4.5B CNY

Tianjin Tianyao Pharmaceuticals Co Ltd
Investor Relations

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, development, production, and sales of corticosteroids and amino acid raw materials and preparations. The company is headquartered in Tianjin, Tianjin and currently employs 2,635 full-time employees. The company went IPO on 2001-06-18. The firm's primary products include corticosteroid bulk pharmaceutical chemicals (BPCs), amino acid BPCs and intermediate, such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinolone acetate, prednisone acetate, triamcinolone acetonide, propranolol propionate and betamethasone, among others. The firm mainly distributes its products in domestic and overseas markets.

Show more
Loading
600488
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Shuxiang Li
GM & Director
No Bio Available
Mr. Liyan Zhu
CFO & Director
No Bio Available
Mr. Hao Liu
Deputy GM & Director
No Bio Available
Ms. Wang Chunli
Board Secretary
No Bio Available

Contacts

Address
TIANJIN
Tianjin
No.19, Xinye 9th Street, West Area, Development Zone
Contacts
+862265277565
www.tjpcty.com